{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:39:55Z","timestamp":1794947995679,"version":"4.9.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T00:00:00Z","timestamp":1607817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Mexican National Council for Science and Technology (CONACYT","award":["472298"],"award-info":[{"award-number":["472298"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine the association between comorbidities and serum urate (SU), gout and comorbidities, and to determine whether the association between gout and comorbidities is independent of SU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a case\u2013control study using UK Biobank data. Two separate analyses were conducted: one excluding participants with gout to investigate the association between comorbidities and SU and the other with participants with gout as the index condition to examine the association between gout and comorbidities. SU was measured at the baseline visit. Self-reported physician-diagnosed illnesses were used to define gout and comorbidities, except for chronic kidney disease (CKD), which was defined using an estimated glomerular filtration rate cut-off. Participants prescribed urate-lowering treatment were also classified as gout. Logistic regression was used to examine associations. Odds ratios (ORs) and 95% CIs were calculated and adjusted for covariates including comorbidities and SU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Data for 458\u00a0781 UK Biobank participants were used to examine the association between comorbidities and SU. There was an association between hypertension, ischaemic heart disease (IHD), congestive cardiac failure (CCF), hyperlipidaemia, CKD and SU with and adjusted OR (aOR) of 1.10\u20133.14 for each 1\u2009mg\/dl SU increase. A total of 10\u00a0265 gout cases and 458\u00a0781 controls were included in the analysis of association between gout and comorbidities. Gout associated independently with hypertension, IHD, CCF, hyperlipidaemia and diabetes, with aORs of 1.21\u20134.15 after adjusting for covariates including SU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Comorbidities associate with increasing SU. The association between gout and cardiometabolic comorbidities was independent of SU, suggesting separate SU-independent mechanisms such as inflammation driven by crystal deposition, pro-inflammatory genotype or non-purine dietary factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa773","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T07:22:22Z","timestamp":1604906542000},"page":"3243-3251","source":"Crossref","is-referenced-by-count":35,"title":["Association between serum urate, gout and comorbidities: a case\u2013control study using data from the UK Biobank"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7809-7864","authenticated-orcid":false,"given":"Gabriela","family":"Sandoval-Plata","sequence":"first","affiliation":[{"name":"Academic Rheumatology, University of Nottingham, Nottingham, UK"},{"name":"Nottingham National Institute for Health Research Biomedical Research Centre, Nottingham, UK"},{"name":"Human Genetics, School of Life Sciences, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Nakafero","sequence":"additional","affiliation":[{"name":"Academic Rheumatology, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithun","family":"Chakravorty","sequence":"additional","affiliation":[{"name":"Academic Rheumatology, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Morgan","sequence":"additional","affiliation":[{"name":"Human Genetics, School of Life Sciences, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Abhishek","sequence":"additional","affiliation":[{"name":"Academic Rheumatology, University of Nottingham, Nottingham, UK"},{"name":"Nottingham National Institute for Health Research Biomedical Research Centre, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,13]]},"reference":[{"key":"2021070122141355100_keaa773-B1","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007\u20132016","volume":"71","author":"Chen-Xu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2021070122141355100_keaa773-B2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021070122141355100_keaa773-B3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/rheumatology\/ker361","article-title":"National prevalence of gout derived from administrative health data in Aotearoa New Zealand","volume":"51","author":"Winnard","year":"2012","journal-title":"Rheumatology"},{"key":"2021070122141355100_keaa773-B4","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/key096","article-title":"Comorbidity clusters in people with gout: an observational cohort study with linked medical record review","volume":"57","author":"Bevis","year":"2018","journal-title":"Rheumatology (Oxford"},{"key":"2021070122141355100_keaa773-B5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/annrheumdis-2013-203779","article-title":"Revisiting comorbidities in gout: a cluster analysis","volume":"74","author":"Richette","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021070122141355100_keaa773-B6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","article-title":"Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007\u20132008","volume":"125","author":"Zhu","year":"2012","journal-title":"Am J Med"},{"key":"2021070122141355100_keaa773-B7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/annrheumdis-2014-206410","article-title":"Comorbidities in patients with gout prior to and following diagnosis: case-control study","volume":"75","author":"Kuo","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021070122141355100_keaa773-B8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/rheumatology\/kev418","article-title":"Impact of gout on the risk of atrial fibrillation","volume":"55","author":"Kuo","year":"2016","journal-title":"Rheumatology (Oxford"},{"key":"2021070122141355100_keaa773-B9","doi-asserted-by":"crossref","first-page":"e1002937","DOI":"10.1371\/journal.pmed.1002937","article-title":"Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: a phenome-wide Mendelian randomization study","volume":"16","author":"Li","year":"2019","journal-title":"PLoS Med"},{"key":"2021070122141355100_keaa773-B10","doi-asserted-by":"crossref","first-page":"e1002725","DOI":"10.1371\/journal.pmed.1002725","article-title":"No causal effects of serum urate levels on the risk of chronic kidney disease: a Mendelian randomization study","volume":"16","author":"Jordan","year":"2019","journal-title":"PLoS Med"},{"key":"2021070122141355100_keaa773-B11","doi-asserted-by":"crossref","first-page":"e000834","DOI":"10.1136\/bmjdrc-2019-000834","article-title":"Mendelian randomization study of serum uric acid levels and diabetes risk: evidence from the Dongfeng-Tongji cohort","volume":"8","author":"Keerman","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2021070122141355100_keaa773-B12","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s00125-011-2235-0","article-title":"No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach","volume":"54","author":"Pfister","year":"2011","journal-title":"Diabetologia"},{"key":"2021070122141355100_keaa773-B13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13075-017-1390-1","article-title":"Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank","volume":"19","author":"Cadzow","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2021070122141355100_keaa773-B14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2021070122141355100_keaa773-B15","doi-asserted-by":"crossref","first-page":"e000326","DOI":"10.1136\/rmdopen-2016-000326","article-title":"Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective","volume":"2","author":"Kapetanovic","year":"2016","journal-title":"RMD Open"},{"key":"2021070122141355100_keaa773-B16","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/acr.23562","article-title":"Gout severity, socioeconomic status, and work absence: a cross-sectional study in primary care","volume":"70","author":"Bowen-Davies","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2021070122141355100_keaa773-B17","year":"2015"},{"key":"2021070122141355100_keaa773-B18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCHEARTFAILURE.108.797662","article-title":"Hyperuricemia and incident heart failure","volume":"2","author":"Krishnan","year":"2009","journal-title":"Circ Heart Fail"},{"key":"2021070122141355100_keaa773-B19","doi-asserted-by":"crossref","first-page":"19520","DOI":"10.1038\/srep19520","article-title":"Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"2021070122141355100_keaa773-B20","doi-asserted-by":"crossref","first-page":"e114259","DOI":"10.1371\/journal.pone.0114259","article-title":"Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"2021070122141355100_keaa773-B21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12872-016-0379-z","article-title":"Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies","volume":"16","author":"Zuo","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"2021070122141355100_keaa773-B22","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0272-6386(04)00934-5","article-title":"Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort","volume":"44","author":"Iseki","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2021070122141355100_keaa773-B23","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jash.2015.05.010","article-title":"Uric acid levels within the normal range predict increased risk of hypertension: a cohort study","volume":"9","author":"Leiba","year":"2015","journal-title":"J Am Soc Hypertens"},{"key":"2021070122141355100_keaa773-B24","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1136\/ard.2010.130013","article-title":"Impact of diabetes against the future risk of developing gout","volume":"69","author":"Rodr\u00edguez","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2021070122141355100_keaa773-B25","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3949\/ccjm.75.Suppl_5.S13","article-title":"The role of hyperuricemia and gout in kidney and cardiovascular disease","volume":"75","author":"Edwards","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"2021070122141355100_keaa773-B26","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"Johnson","year":"2003","journal-title":"Hypertension"},{"key":"2021070122141355100_keaa773-B27","article-title":"Mortality in patients with gout treated with allopurinol: a systematic review and meta-analysis","author":"Hay","year":"2020","journal-title":"Arthritis Care Res"},{"key":"2021070122141355100_keaa773-B28","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/art.40486","article-title":"Allopurinol dose escalation and mortality among patients with gout","volume":"70","author":"Coburn","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2021070122141355100_keaa773-B29","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/annrheumdis-2014-205269","article-title":"Allopurinol initiation and all-cause mortality in the general population","volume":"74","author":"Dubreuil","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021070122141355100_keaa773-B30","doi-asserted-by":"crossref","first-page":"e005308","DOI":"10.1136\/bmjopen-2014-005308","article-title":"Prevalence of birefringent crystals in cardiac and prostatic tissues, an observational study","volume":"4","author":"Park","year":"2014","journal-title":"BMJ Open"},{"key":"2021070122141355100_keaa773-B31","article-title":"Asymptomatic monosodium urate crystal deposition associates with increased expression of pro-inflammatory genes","volume":"71(Suppl 10","author":"Sandoval-Plata","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2021070122141355100_keaa773-B32","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"2021070122141355100_keaa773-B33","doi-asserted-by":"crossref","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"key":"2021070122141355100_keaa773-B34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12979-015-0047-7","article-title":"NLR family pyrin domain containing 3 (NLRP3) inflammasome gene polymorphism rs7512998 (C&gt;T) predicts aging-related increase of blood pressure, the TAMRISK study","volume":"12","author":"Kunnas","year":"2015","journal-title":"Immun Ageing"},{"key":"2021070122141355100_keaa773-B35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12979-015-0031-2","article-title":"Association of Toll-like receptor 4 polymorphism with age-dependent systolic blood pressure increase in patients with coronary artery disease","volume":"12","author":"Schneider","year":"2015","journal-title":"Immun Ageing"},{"key":"2021070122141355100_keaa773-B36","doi-asserted-by":"crossref","first-page":"e003031","DOI":"10.1161\/JAHA.115.003031","article-title":"NLRP3 Inflammasome expression and activation in human atherosclerosis","volume":"5","author":"Paramel Varghese","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2021070122141355100_keaa773-B37","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s12026-017-8924-0","article-title":"The NLRP3 and CASP1 gene polymorphisms are associated with developing of acute coronary syndrome: a case-control study","volume":"65","author":"Gonzalez-Pacheco","year":"2017","journal-title":"Immunol Res"},{"key":"2021070122141355100_keaa773-B38","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s13075-015-0802-3","article-title":"Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout","volume":"17","author":"McKinney","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2021070122141355100_keaa773-B39","doi-asserted-by":"crossref","first-page":"j2376","DOI":"10.1136\/bmj.j2376","article-title":"Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies","volume":"357","author":"Li","year":"2017","journal-title":"BMJ"},{"key":"2021070122141355100_keaa773-B40","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/annrheumdis-2015-208767","article-title":"Low omega-3 fatty acid levels associate with frequent gout attacks: a case control study","volume":"75","author":"Abhishek","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021070122141355100_keaa773-B41","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/art.40896","article-title":"Effect of dietary and supplemental omega-3 polyunsaturated fatty acids on risk of recurrent gout flares","volume":"71","author":"Zhang","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2021070122141355100_keaa773-B42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(15)60175-1","article-title":"5 year mortality predictors in 498\u00a0103 UK Biobank participants: a prospective population-based study","volume":"386","author":"Ganna","year":"2015","journal-title":"Lancet"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/7\/3243\/38850076\/keaa773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/7\/3243\/38850076\/keaa773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T18:21:37Z","timestamp":1625163697000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/7\/3243\/6032841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,13]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,12,13]]},"published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa773","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2020,12,13]]}}}